Add BrightSurf on Google Email

Safer viruses for vaccine research and diagnosis

Researchers have developed a new biotechnology platform to produce safer 'hybrid' viruses for vaccines and diagnostics against mosquito-borne diseases. The Binjari virus, inert to humans, is used to create 'dangerous-looking' viruses like Zika and dengue that cannot grow in humans or animals.

SourceUniversity of Queensland·JournalScience Translational Medicine·DateDec 11, 2019

Scientists crack rabies virus weaponry

Researchers have discovered a way to stop the rabies virus from shutting down the immune system, solving a long-standing scientific puzzle. The breakthrough involves disabling the binding of viral proteins to host cells' STAT1 protein, paving the way for new oral vaccines.

SourceUniversity of Melbourne·JournalCell Reports·DateNov 12, 2019

Yale researchers detect unreported Zika outbreak

Researchers detected a large unreported Zika outbreak in Cuba during 2017, using virus genomics and travel patterns to identify the outbreak. The study suggests that effective mosquito control campaigns can delay outbreaks, emphasizing the need for alternative detection methods when local case reporting is limited.

SourceYale University·JournalCell·DateAug 22, 2019

Major class of viruses reveals complex origins

A new study reveals that circular Rep-encoding single-stranded DNA viruses have acquired their genetic components through complex evolutionary processes. The findings show that these viruses are 'obsessive borrowers', appropriating genetic material from various sources, including bacterial and eukaryotic cells.

SourceArizona State University·JournalNature Communications·DateJul 31, 2019

Simultaneous infection by 2 viruses the key to studying rare lymphoma

Researchers have successfully created stable, cancer-like cells in the lab by simultaneously infecting white blood cells with two viruses, Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus. This breakthrough opens up new opportunities for understanding the progression of this rare blood cancer and developing treatments.

SourceUniversity of Wisconsin-Madison·JournalProceedings of the National Academy of Sciences·DateJul 29, 2019

The start of a new era in stem cell therapy

A recent study has improved upon Nobel Laureate Prof. Shinya Yamanaka's cellular reprogramming method, reducing the waiting period from 3-4 weeks to approximately a week. The new method also increases the success rate up to ten-fold, making it easier to apply in clinical settings.

SourceKoc University·JournalNature Chemical Biology·DateJun 13, 2019

New vulnerability found in major human viruses

Researchers identified a previously unknown pocket on the surface of picornaviruses, which can be stabilized by a newly-discovered compound. This stabilization prevents shape change and interaction with host cells, making it a promising strategy for developing antiviral medications.

SourcePLOS·JournalPLOS Biology·DateJun 11, 2019

New research helping to reveal more about megaviruses

Researchers from Swansea University have published a study examining the unexpected genes carried by these giant viruses found inside amoebae. The findings provide valuable information on how these viruses may be linked to some forms of pneumonia, paving the way for new treatments and understanding their biology.

SourceSwansea University·JournalProceedings of the National Academy of Sciences·DateJun 6, 2019

From viruses to social bots, researchers unearth the structure of attacked networks

A new statistical machine learning framework has been developed to reconstruct the original network after a viral attack, which is crucial for designing new medicines or gene therapies against viruses and diseases like cancer. The framework actively incorporates the influence and causality of the attack into its learning algorithm.

SourceUniversity of Southern California·JournalNature Communications·DateMay 29, 2019

How host-cell enzymes combat the coronavirus

A study found that host-cell enzymes PARP12 and PARP14 play a crucial role in combating mutant coronavirus replication. The macrodomain of the virus is required to prevent these enzymes from inhibiting viral replication and enhancing the production of antiviral proteins.

SourcePLOS·JournalPLOS Pathogens·DateMay 16, 2019

Online intervention reduces mothers' intentions to visit doctor for respiratory tract infection

An online intervention with real-time information on locally circulating viruses reduced mothers' intentions to visit the doctor for a respiratory tract infection. Participants in the intervention group had lower intentions than those in the control group, according to the study published in The Annals of Family Medicine.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMay 14, 2019

1 billion people will be newly exposed to diseases like dengue fever as world temperatures rise

A new study warns that global warming could lead to the spread of disease-carrying mosquitoes to areas previously too cold for them, putting 1 billion people at risk. The research suggests that temperatures are expected to rise, leading to year-round transmissions in tropical regions and seasonal risks elsewhere.

SourceGeorgetown University Medical Center·JournalPLOS Neglected Tropical Diseases·DateMar 28, 2019

Modelled climate change impact on mosquito-borne virus transmission

A study predicts climate change will lead to increased and new exposures to humans of diseases carried by mosquito vectors, with poleward shifts in Aedes-borne virus distributions. The model suggests a middle-of-the-road temperature increase could produce the greatest expansion in viral transmission by Ae. albopictus.

SourcePLOS·JournalPLOS ONE·DateMar 28, 2019